Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity
Oncotarget (2015) - Comments
pubmed: 25883215  doi: 10.18632/oncotarget.3628  issn: 1949-2553 

Jessica Frankum, Pavel Moudry, Rachel Brough, Zdenek Hodny, Alan Ashworth, Jiri Bartek, Christopher J. Lord